36157-42-3Relevant articles and documents
5-chloro-3-thiophenecarboxylic acid preparation method
-
Paragraph 0020; 0021, (2016/11/24)
The present invention discloses a 5-chloro-3-thiophenecarboxylic acid preparation method comprising the following steps: (1) adding 3-thiophenecarboxylic acid and an organic solvent into a reaction vessel, reducing the temperature to 0 DEG C to -30 DEG C, adding dropwise sulfuryl chloride into the reaction vessel, and after the addition is complete, heating slowly to 0 DEG C-20 DEG C for reaction for 1 to 3 hours; (2) after completion of the reaction, pouring the reaction solution into ice water, layering the reaction solution, separating an organic layer, drying the organic layer, filtering and concentrating to obtain a crude 5-chloro-3-thiophenecarboxylic acid product; (3) using methyl tert-butyl ether for recrystallizing the crude 5-chloro-3-thiophenecarboxylic acid product obtained in the step (2), filtering to obtain a crystal solid, and drying the crystal solid to obtain a pure 5-chloro-3-thiophenecarboxylic acid product. The novel 5-chloro-3-thiophenecarboxylic acid preparation method is provided, and a 5-chloro-3-thiophenecarboxylic acid product with a purity of 97% can be obtained.
Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies
Whittamore, Paul R.O.,Addie, Matthew S.,Bennett, Stuart N.L.,Birch, Alan M.,Butters, Michael,Godfrey, Linda,Kenny, Peter W.,Morley, Andrew D.,Murray, Paul M.,Oikonomakos, Nikos G.,Otterbein, Ludovic R.,Pannifer, Andrew D.,Parker, Jeremy S.,Readman, Kristy,Siedlecki, Pawel S.,Schofield, Paul,Stocker, Andy,Taylor, Melvyn J.,Townsend, Linda A.,Whalley, David P.,Whitehouse, Jennifer
, p. 5567 - 5571 (2007/10/03)
Two series of novel thienopyrrole inhibitors of recombinant human liver glycogen phosphorylase a (GPa) which are effective in reducing glucose output from rat hepatocytes are described. Representative compounds have been shown to bind at the dimer interface site of the rabbit muscle enzyme by X-ray crystallography.
Phosphorylamides, their preparation and use
-
, (2008/06/13)
A phosphorylamide derivative represented by the general formula (I): STR1 wherein R represents an amino group that may be substituted, or a salt thereof, possesses potent antibacterial activity against Helicobacter bacterium, especially Helicobacter pylori, and is useful for prevention or treatment of digestive diseases caused by Helicobacter bacterium, solely or in combination with an antacid or an acid secretion inhibitor.